Incredible video captures two thieves angle-grinding their way into a pharmacy's safe in TWO-HOUR robbery that netted them $1million worth of drugs
Police are searching for two men who broke into a Texas pharmacy on New Year's Eve stealing $1million in prescription drugs, the Daily Mail reports.
Surveillance video from the Super Value Pharmacy in Euless, Texas caught the brazen two-hour long robbery on camera.
The video shows the two men crawling on the floor to avoid motion detectors before stealing numerous bottles of cough syrup.
They left the pharmacy and returned with a bag full of tools.
Two men broke into the #SuperValuePharmacy in #Euless, #Texas on #NewYear's Eve https://t.co/CuyQGxlweO #ZippedNews https://t.co/CVa8GbMcVL
— News in Summary (@news_in_summary) January 22, 2016
Jean Badham, former chairman of Badham Pharmacy, dies
Jean Badham, who played a big part in the success of her family's chain of Gloucestershire pharmacies, has died, the Gloucestershire Echo reports.
The 86-year-old was a former chairman of the Badham Pharmacy company, which operates 15 pharmacies in Gloucestershire and one in Bristol.
But her son John, who is Tewkesbury's town mayor, said she had been much more than an important part of the business.
He said: "She will be remembered as a truly lovely lady who brightened the lives of so many over her long life. Her generosity was legendary. She gave lavishly to many charities, particularly those involving children and veterans.”
Jean Badham, former chairman of Badham Pharmacy, dies - Gloucestershire Echo https://t.co/10inl0dpVc
— Global Pharma News (@pharma_global) January 21, 2016
POLICE APPEAL: Man leaves empty-handed after attempted robbery in Darwen
A manhunt has been launched after a pharmacy in Darwen was targeted yesterday, the Lancashire Telegraph reports.
Police are searching for a man who demanded money from a shop assistant at Everest Pharmacy, Cemetery Road at around 5.30pm.
The assistant refused to hand over any money and the man left empty-handed.
He is described as white, medium build, around 5ft 9in tall and was wearing black waterproof type clothing and black gloves.
He had his hood up and covered his face with a black scarf and spoke with a local accent.
Attempted robbery at a Darwen pharmacy: https://t.co/iKfRouhgI9 pic.twitter.com/rI65OwoLpe
— The Bee (@thebeeofficial) January 21, 2016
Celesio in exclusivity to acquire Bupa’s home care division
German firm Celesio, which owns Lloyds Pharmacy, is in exclusive talks to acquire the home care division of Bupa, Health Investor reports.
Celesio already owns a domiciliary care firm – Evolution Homecare, which provides clinical homecare services across the UK.
Bupa Home Healthcare provides domiciliary care services, ranging from medication delivery to specialist nursing care, to around 35,500 people. The division has been a problematic one for Bupa, however; the company wrote £32.8 million off its value in 2013 due to low public sector fees.
German giant #Celesio swoops for #Bupa #homecare business https://t.co/UHZLjjQn7b
— CareEnglandNews (@CareEnglandNews) January 16, 2016
Diabetes: Government and NHS too slow to act, say MPs
MPs have criticised the Department of Health and the NHS in England for being "too slow" to act in preventing and treating diabetes, the BBC reports.
A report by the Public Accounts Committee says variations in the care of both type 1 and 2 diabetes mean the annual cost to the health service will continue to rise.
For people aged 16 and over the bill currently stands at £5.5bn a year.
The government said "big improvements in diabetes care" had been made.
But a Department of Health spokesman added: "Any variation in care, as this report highlights, is deeply concerning.
The number of people with diabetes is rising and not enough is being done about it, MPs warn https://t.co/svd5co300u
— BBC News (UK) (@BBCNews) January 22, 2016
New drug approved for skin cancer treatment on NHS
A groundbreaking new drug for skin cancer has been given the go-ahead for use in the NHS after England's drug cost watchdog decided that the £5,700 per month price was good value for money, The Telegraph reports.
The National Institute for Health and Care Excellence (Nice) recommended nivolumab, (also called Opdivo), a type of immunotherapy which stimulates the body's immune system to fight cancer cells.
Research has found that melanoma patients survive much longer on the drug, which is administered by drip, than those given conventional chemotherapy.
The one-year survival rate was 73 per cent for those on nivolumab compared to 42 per cent for chemotherapy.
New drug which almost doubles skin cancer survival rates gets approval for use by NHS https://t.co/9Rzs21703w pic.twitter.com/ANbdWvcoEK
— Daily Mirror (@DailyMirror) January 22, 2016
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.